-
1
-
-
0036905983
-
Comparison of the effects of antidepressants on norepinephrine and serotonin concentrations in the rat frontal cortex: an in-vivo microdialysis study
-
Beyer C.E., Boikess S., Luo B., Dawson L.A. Comparison of the effects of antidepressants on norepinephrine and serotonin concentrations in the rat frontal cortex: an in-vivo microdialysis study. J Psychopharmacol 2002, 16:297-304.
-
(2002)
J Psychopharmacol
, vol.16
, pp. 297-304
-
-
Beyer, C.E.1
Boikess, S.2
Luo, B.3
Dawson, L.A.4
-
2
-
-
53649086029
-
The triple monoaminergic reuptake inhibitor DOV 216,303 has antidepressant effects in the rat olfactory bulbectomy model and lacks sexual side effects
-
Breuer M.E., Chan J.S., Oosting R.S., Groenink L., Korte S.M., Campbell U., Schreiber R., Hanania T., Snoeren E.M., Waldinger M., Olivier B. The triple monoaminergic reuptake inhibitor DOV 216,303 has antidepressant effects in the rat olfactory bulbectomy model and lacks sexual side effects. Eur Neuropsychopharmacol 2008, 18:908-916.
-
(2008)
Eur Neuropsychopharmacol
, vol.18
, pp. 908-916
-
-
Breuer, M.E.1
Chan, J.S.2
Oosting, R.S.3
Groenink, L.4
Korte, S.M.5
Campbell, U.6
Schreiber, R.7
Hanania, T.8
Snoeren, E.M.9
Waldinger, M.10
Olivier, B.11
-
3
-
-
0035677108
-
Comparative affinity of duloxetine and venlafaxine for serotonin and norepinephrine transporters in vitro and in vivo, human serotonin receptor subtypes, and other neuronal receptors
-
Bymaster F.P., Dreshfield-Ahmad L.J., Threlkeld P.G., Shaw J.L., Thompson L., Nelson D.L., Hemrick-Luecke S.K., Wong D.T. Comparative affinity of duloxetine and venlafaxine for serotonin and norepinephrine transporters in vitro and in vivo, human serotonin receptor subtypes, and other neuronal receptors. Neuropsychopharmacology 2001, 25:871-880.
-
(2001)
Neuropsychopharmacology
, vol.25
, pp. 871-880
-
-
Bymaster, F.P.1
Dreshfield-Ahmad, L.J.2
Threlkeld, P.G.3
Shaw, J.L.4
Thompson, L.5
Nelson, D.L.6
Hemrick-Luecke, S.K.7
Wong, D.T.8
-
4
-
-
78649618505
-
The novel triple reuptake inhibitor JZAD-IV-22 exhibits an antidepressant pharmacological profile without locomotor stimulant or sensitization properties
-
Caldarone B.J., Paterson N.E., Zhou J., Brunner D., Kozikowski A.P., Westphal K.G., Korte-Bouws G.A., Prins J., Korte S.M., Olivier B., Ghavami A. The novel triple reuptake inhibitor JZAD-IV-22 exhibits an antidepressant pharmacological profile without locomotor stimulant or sensitization properties. J Pharmacol Exp Ther 2010, 335:762-770.
-
(2010)
J Pharmacol Exp Ther
, vol.335
, pp. 762-770
-
-
Caldarone, B.J.1
Paterson, N.E.2
Zhou, J.3
Brunner, D.4
Kozikowski, A.P.5
Westphal, K.G.6
Korte-Bouws, G.A.7
Prins, J.8
Korte, S.M.9
Olivier, B.10
Ghavami, A.11
-
5
-
-
0036570222
-
Assessing antidepressant activity in rodents: recent developments and future needs
-
Cryan J.F., Markou A., Lucki I. Assessing antidepressant activity in rodents: recent developments and future needs. Trends Pharmacol Sci 2002, 23:238-245.
-
(2002)
Trends Pharmacol Sci
, vol.23
, pp. 238-245
-
-
Cryan, J.F.1
Markou, A.2
Lucki, I.3
-
6
-
-
0034730472
-
The role of dopamine in the mechanism of action of antidepressant drugs
-
D'Aquila P.S., Collu M., Gessa G.L., Serra G. The role of dopamine in the mechanism of action of antidepressant drugs. Eur J Pharmacol 2000, 405:365-373.
-
(2000)
Eur J Pharmacol
, vol.405
, pp. 365-373
-
-
D'Aquila, P.S.1
Collu, M.2
Gessa, G.L.3
Serra, G.4
-
7
-
-
33745958408
-
Desvenlafaxine succinate: a new serotonin and norepinephrine reuptake inhibitor
-
Deecher D.C., Beyer C.E., Johnston G., Bray J., Shah S., Abou-Gharbia M., Andree T.H. Desvenlafaxine succinate: a new serotonin and norepinephrine reuptake inhibitor. J Pharmacol Exp Ther 2006, 318:657-665.
-
(2006)
J Pharmacol Exp Ther
, vol.318
, pp. 657-665
-
-
Deecher, D.C.1
Beyer, C.E.2
Johnston, G.3
Bray, J.4
Shah, S.5
Abou-Gharbia, M.6
Andree, T.H.7
-
8
-
-
33847767095
-
The role of dopamine in the pathophysiology of depression
-
Dunlop B.W., Nemeroff C.B. The role of dopamine in the pathophysiology of depression. Arch Gen Psychiatry 2007, 64:327-337.
-
(2007)
Arch Gen Psychiatry
, vol.64
, pp. 327-337
-
-
Dunlop, B.W.1
Nemeroff, C.B.2
-
9
-
-
0032927199
-
Characteristics of drug interactions with recombinant biogenic amine transporters expressed in the same cell type
-
Eshleman A.J., Carmolli M., Cumbay M., Martens C.R., Neve K.A., Janowsky A. Characteristics of drug interactions with recombinant biogenic amine transporters expressed in the same cell type. J Pharmacol Exp Ther 1999, 289:877-885.
-
(1999)
J Pharmacol Exp Ther
, vol.289
, pp. 877-885
-
-
Eshleman, A.J.1
Carmolli, M.2
Cumbay, M.3
Martens, C.R.4
Neve, K.A.5
Janowsky, A.6
-
10
-
-
33746059642
-
Animal models for better antidepressants: can pathogenetic approaches make a difference?
-
Harro J. Animal models for better antidepressants: can pathogenetic approaches make a difference?. Preclinica 2004, 2:402-407.
-
(2004)
Preclinica
, vol.2
, pp. 402-407
-
-
Harro, J.1
-
11
-
-
0018268297
-
Behavioural despair in rats: a new model sensitive to antidepressant treatments
-
Porsolt R.D., Anton G., Blavet N., Jalfre M. Behavioural despair in rats: a new model sensitive to antidepressant treatments. Eur J Pharmacol 1978, 47:379-391.
-
(1978)
Eur J Pharmacol
, vol.47
, pp. 379-391
-
-
Porsolt, R.D.1
Anton, G.2
Blavet, N.3
Jalfre, M.4
-
12
-
-
40149088986
-
Prodrugs: design and clinical applications
-
Rautio J., Kumpulainen H., Heimbach T., Oliyai R., Oh D., Järvinen T., Savolainen J. Prodrugs: design and clinical applications. Nat Rev Drug Discov 2008, 7:255-270.
-
(2008)
Nat Rev Drug Discov
, vol.7
, pp. 255-270
-
-
Rautio, J.1
Kumpulainen, H.2
Heimbach, T.3
Oliyai, R.4
Oh, D.5
Järvinen, T.6
Savolainen, J.7
-
13
-
-
70449720617
-
Dopamine/adenosine interactions involved in effort-related aspects of food motivation
-
Salamone J.D., Correa M. Dopamine/adenosine interactions involved in effort-related aspects of food motivation. Appetite 2009, 53:422-425.
-
(2009)
Appetite
, vol.53
, pp. 422-425
-
-
Salamone, J.D.1
Correa, M.2
-
14
-
-
33845804288
-
Antidepressant-like effects of novel triple reuptake inhibitors, PRC025 and PRC050
-
Shaw A.M., Boules M., Zhang Y., Williams K., Robinson J., Carlier P.R., Richelson E. Antidepressant-like effects of novel triple reuptake inhibitors, PRC025 and PRC050. Eur J Pharmacol 2007, 555:30-36.
-
(2007)
Eur J Pharmacol
, vol.555
, pp. 30-36
-
-
Shaw, A.M.1
Boules, M.2
Zhang, Y.3
Williams, K.4
Robinson, J.5
Carlier, P.R.6
Richelson, E.7
-
15
-
-
33748077457
-
Preclinical and clinical pharmacology of DOV 216, 303, a "triple" reuptake inhibitor. CNS
-
Skolnick P., Krieter P., Tizzano J., Basile A., Popik P., Czobor P., Lippa A. Preclinical and clinical pharmacology of DOV 216, 303, a "triple" reuptake inhibitor. CNS. Drug Rev 2006, 12:123-134.
-
(2006)
Drug Rev
, vol.12
, pp. 123-134
-
-
Skolnick, P.1
Krieter, P.2
Tizzano, J.3
Basile, A.4
Popik, P.5
Czobor, P.6
Lippa, A.7
-
16
-
-
12244291291
-
Antidepressant-like actions of DOV 21,947: a "triple" reuptake inhibitor
-
Skolnick P., Popik P., Janowsky A., Beer B., Lippa A.S. Antidepressant-like actions of DOV 21,947: a "triple" reuptake inhibitor. Eur J Pharmacol 2003, 461:99-104.
-
(2003)
Eur J Pharmacol
, vol.461
, pp. 99-104
-
-
Skolnick, P.1
Popik, P.2
Janowsky, A.3
Beer, B.4
Lippa, A.S.5
-
17
-
-
0021990491
-
The tail suspension test: a new method for screening antidepressants in mice
-
Steru L., Chermat R., Thierry B., Simon P. The tail suspension test: a new method for screening antidepressants in mice. Psychopharmacology (Berl) 1985, 85:367-370.
-
(1985)
Psychopharmacology (Berl)
, vol.85
, pp. 367-370
-
-
Steru, L.1
Chermat, R.2
Thierry, B.3
Simon, P.4
-
18
-
-
0037311073
-
Dual monoamine modulation for improved treatment of major depressive disorder
-
Tran P.V., Bymaster F.P., McNamara R.K., Potter W.Z. Dual monoamine modulation for improved treatment of major depressive disorder. J Clin Psychopharmacol 2003, 23:78-86.
-
(2003)
J Clin Psychopharmacol
, vol.23
, pp. 78-86
-
-
Tran, P.V.1
Bymaster, F.P.2
McNamara, R.K.3
Potter, W.Z.4
-
19
-
-
0035348160
-
Research and treatment approaches to depression
-
Wong M.L., Licinio J. Research and treatment approaches to depression. Nat Rev Neurosci 2001, 2:343-351.
-
(2001)
Nat Rev Neurosci
, vol.2
, pp. 343-351
-
-
Wong, M.L.1
Licinio, J.2
-
20
-
-
32144448883
-
Use of bupropion in combination with serotonin reuptake inhibitors
-
Zisook S., Rush A.J., Haight B.R., Clines D.C., Rockett C.B. Use of bupropion in combination with serotonin reuptake inhibitors. Biol Psychiatry 2006, 59:203-210.
-
(2006)
Biol Psychiatry
, vol.59
, pp. 203-210
-
-
Zisook, S.1
Rush, A.J.2
Haight, B.R.3
Clines, D.C.4
Rockett, C.B.5
|